Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allarity Therapeutics (ALLR) Treasury Shares (2024 - 2025)

Allarity Therapeutics' Treasury Shares history spans 1 years, with the latest figure at $3.2 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 256.34% year-over-year to $620164.0; the TTM value through Dec 2025 reached $620164.0, up 256.34%, while the annual FY2025 figure was $620164.0, 256.34% up from the prior year.
  • Treasury Shares reached $620164.0 in Q4 2025 per ALLR's latest filing, roughly flat from $620164.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $744709.0 in Q2 2025 to a low of $174038.0 in Q3 2024.